DAX
±0,00
%
Gold
±0,00
%
BörsenNEWS.de
Home
Börse
Märkte
Trends
Aktien
Indizes
Rohstoffe
Crypto
Derivate
Analyse
Niedrigstes KGV
Beste Dividende
Marktkapitalisierung
Meistgehandelt
Beste Performance
Termine
Handelskalender
Verfallstage
Community
Foren Übersicht
Meistdiskutiert
Community
News
Aktien
Indizes
Rohstoffe
Fonds
Anleihen
Zertifikate
Optionsscheine
Devisen
Crypto
News
Schlagzeilen
Nachrichten
Community
Meldungen
DAX-News
Dow Jones-News
MDAX-News
Märkte
Aktien
Indizes
Rohstoffe
Devisen
Partner
Archiv
KI-Fragen
Suche
SMARTBROKER
+
Depot
Suche
BörsenNEWS.de
Home
Suche
Suche
Sofort finden was Sie suchen
Alles
News
Aktie
Aktie
AKEBIA THERAPEUTICS
A1XF0S / US00972D1054
1,27
EUR
-0,78
%
News
EQS-News: Planned Government Move To Expand Access To Drugs For End-Stage Renal Disease Patients Could Shine The Spotlight On Unicycive
News
EQS-News: Mighty Mitochondria: This Company is Developing A Novel Drug for Kidney Disease By Targeting The Powerhouse Of Human Cells
News
EQS-News: How One Company Plans To Help Battle A Silent Killer Globally Through Its New Kidney Disease Medication
News
EQS-News: Planned Government Move To Expand Access To Drugs For End-Stage Renal Disease Patients Could Shine The Spotlight On Unicycive
News
EQS-News: Mighty Mitochondria: This Company is Developing A Novel Drug for Kidney Disease By Targeting The Powerhouse Of Human Cells
News
EQS-News: How One Company Plans To Help Battle A Silent Killer Globally Through Its New Kidney Disease Medication
Aktie
AKEBIA THERAPEUTICS
A1XF0S / US00972D1054
1,27
EUR
-0,78
%
Anmelden
Login
Neu hier?
Jetzt Registrieren
Passwort vergessen?
weiter